✦ LIBER ✦

An Anti-Human VEGF Monoclonal Antibody, MV833, That Exhibits Potent Anti-Tumor Activity In Vivo

✍ Scribed by ASANO, MAKOTO; YUKITA, AYAKO; MATSUMOTO, TOMOE; HANATANI, MITSUYA; SUZUKI, HIDEO

Book ID: 121185396
Publisher: Mary Ann Liebert
Year: 1998
Weight: 731 KB
Volume: 17
Category: Article
ISSN: 0272-457X
DOI: 10.1089/hyb.1998.17.185

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enhanced antitumor activity of anti-VEGF

Enhanced antitumor activity of anti-VEGF antibody HuMV833 in combination with gemcitabine in human pancreatic and renal tumor xenografts

✍ A.M. Burger; H.R. Hendriks; H. Zwierzina; H.H. Fiebig 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 104 KB

553 POSTER AP24534: an orally active kin

553 POSTER AP24534: an orally active kinase inhibitor that targets multiple pro-angiogenic receptors and exhibits potent anti-tumor activity in vivo

✍ V.M. Rivera; R. DiRenzo; L. Berk; S. Wardwell; Y. Ning; N.I. Narasimhan; Q. Xu; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Involvement of the VEGF receptor 3 in tu

Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human anti-human VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C

✍ Persaud, K. 📂 Article 📅 2004 🏛 The Company of Biologists Ltd 🌐 English ⚖ 817 KB

64 PDL192, a humanized antibody to Tweak

64 PDL192, a humanized antibody to TweakR exhibits potent anti-tumor activity in non-small cell lung cancer models

✍ B.L. Hylander; M. Sho; S. Tanlimco; D. Choi; H. Kim; D. Chao; E.A. Repasky; K. W 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Anti-tumor activity of the TRA-8 anti-DR

Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model

✍ James E. Kendrick; J. Michael Straughn Jr.; Patsy G. Oliver; Wenquan Wang; Li Na 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 541 KB

Chimeric, divalent and tetravalent anti-

Chimeric, divalent and tetravalent anti-CD19 monoclonal antibodies with potent in vitro and in vivo antitumor activity against human B-cell lymphoma and pre-B acute lymphoblastic leukemia cell lines

✍ Xiao-Yun Liu; Laurentiu M. Pop; Lydia Tsai; Iliodora V. Pop; Ellen S. Vitetta 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 295 KB

## Abstract CD19 is an attractive therapeutic target for treating human B‐cell tumors. In our study, chimeric (c) divalent (cHD37) and tetravalent (cHD37‐DcVV) anti‐CD19 monoclonal antibodies (MAbs) were constructed, expressed and evaluated for their binding to human 19‐positive (CD19^+^) tumor cel